Get FREE tickets to the 10/21 Travel Show - use code TSFWP at checkout

dna helix

On Thursday, a federal appeals court found that Myriad Genetics could maintain its patents related to the BRCA1 and BRCA2 genes.
National Human Genome Research Institute
Copyright © 2017, CT Now
71°